4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Top Cited Papers
Open Access
- 19 July 2018
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 29 (8) , 1634-1657
Abstract
Advanced Breast Cancer (ABC) comprises both locally advanced breast cancer (LABC) and metastatic breast cancer (MBC) [1]. Although treatable, MBC remains virtually an incurable disease with a median overall survival (OS) of ∼3 years and a 5-year survival of only ∼25% [2, 3]. The MBC Decade Report [2] shows that progress has been slow in terms of improved outcomes, quality of life (QoL), awareness and information regarding ABC. More recently, some studies seem to indicate an improvement in OS, mostly due to advances in human epidermal growth factor receptor 2 (HER2)-positive ABC [4–6]. The better survival is seen in an environment with access to the best available care and particularly in de novo ABC, while recurrent ABC seems to become harder to manage [7, 8].Keywords
This publication has 71 references indexed in Scilit:
- Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgeryNeuro-Oncology, 2013
- Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patientsEuropean Journal of Medical Research, 2012
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO StudyJournal of Clinical Oncology, 2012
- 1st International consensus guidelines for advanced breast cancer (ABC 1)The Breast, 2012
- Preoperative radio-chemotherapy in early breast cancer patients: Long-term results of a phase II trialRadiotherapy and Oncology, 2012
- Clinical Presentation and Management of Hand–Foot Skin Reaction Associated with Sorafenib in Combination with Cytotoxic Chemotherapy: Experience in Breast CancerThe Oncologist, 2011
- Randomized Double-Blind Placebo-Controlled Trial of Bevacizumab Therapy for Radiation Necrosis of the Central Nervous SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancerBreast Cancer Research and Treatment, 2011
- Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosisJournal of Neuro-Oncology, 2009
- Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2001